GPR161 Antibodies

Santa Cruz Biotechnology provides a broad selection of GPR161 monoclonal antibodies for research focused on understanding this important signaling protein. GPR161 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GPR161 is a G protein-coupled receptor that plays a critical role in regulating signaling pathways involved in cellular processes such as proliferation and differentiation. GPR161 signaling is particularly significant in developmental biology and cancer research, as alterations in its activity can impact tumorigenesis and other pathological conditions. Research has shown that GPR161 influences multiple cellular pathways, making it an important target for scientific investigation. Understanding GPR161 mechanisms can provide valuable insights into potential therapeutic targets for various diseases. Investigating GPR161 function and regulation continues to reveal new aspects of cellular signaling networks. GPR161 research has implications for both basic science and clinical applications, from developmental studies to cancer therapeutics. Santa Cruz Biotechnology monoclonal antibodies for GPR161 enable researchers worldwide to advance scientific understanding of cellular signaling pathways and disease mechanisms.